Home › NDC Lookup › RxCUI directory › RxCUI 2059292

Omadacycline 100 MG Injection [Nuzyra] — RxCUI 2059292

Name: Omadacycline 100 MG Injection [Nuzyra] (RxCUI 2059292)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2059292 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2059292

Official nameOmadacycline 100 MG Injection [Nuzyra]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asNuzyra 100 MG Injection

FDA products mapped2

Package NDCs mapped3

Reported Medicaid activity (SDUD)2,212 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omadacycline: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

No, Nuzyra is specifically approved for two types of bacterial infections in adults: community-acquired bacterial pneumonia (a lung infection you develop outside a hospital) and ac...
What is Nuzyra actually treating — is it for any type of infection?
It really does matter with this one. Studies showed that eating a high-fat meal — especially one with dairy — before taking the Nuzyra tablet can cut the amount your body absorbs b...
Why do I have to take the tablet on such an empty stomach? That seems strict.

📖 Read our full Omadacycline guide →

🕸️ Concept Web — How Omadacycline 100 MG Injection [Nuzyra] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Omadacycline 100 MG Injection [Nuzyra] RxCUI 2059292 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Omadacycline 2059269 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Nuzyra 2059275 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Omadacycline Injection 2059287 SCDF
- Omadacycline Injectable Product 2059286 SCDG
- Omadacycline Injection [Nuzyra] 2059290 SBDF
- Nuzyra Injectable Product 2059291 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Omadacycline 100 MG Injection 2059288 SCD
- Omadacycline 100 MG 2059285 SCDC
- Omadacycline 100 MG [Nuzyra] 2059289 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Omadacycline 100 MG Injection SCD · 2059288
Omadacycline 100 MG SCDC · 2059285
Omadacycline Injection SCDF · 2059287
Omadacycline Injectable Product SCDG · 2059286

Brand-Name Concepts

Omadacycline 100 MG [Nuzyra] SBDC · 2059289
Omadacycline Injection [Nuzyra] SBDF · 2059290
Nuzyra Injectable Product SBDG · 2059291
Nuzyra BN · 2059275

📦 FDA Products & Package NDCs

2 products · 3 package NDCs

3 package NDCs map to RxCUI 2059292 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71715-0001-02	10 VIAL, GLASS in 1 CARTON (71715-001-02) / 10 mL in 1 VIAL...	NUZYRA	Paratek Pharmaceuticals, Inc.	2019-02-01
71715-0002-21	1 BLISTER PACK in 1 CARTON (71715-002-21) / 6 TABLET, FILM...	NUZYRA	Paratek Pharmaceuticals, Inc.	2020-02-01
71715-0002-27	5 BLISTER PACK in 1 CARTON (71715-002-27) / 6 TABLET, FILM...	NUZYRA	Paratek Pharmaceuticals, Inc.	2020-02-01

Observed labelers: Paratek Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0121	Inj., omadacycline, 1 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.